LEADER 03024nam 2200577 a 450 001 9910812828503321 005 20240516162410.0 010 $a1-280-56917-4 010 $a9786613598776 010 $a1-935281-30-5 035 $a(CKB)2670000000180880 035 $a(EBL)914704 035 $a(OCoLC)793511319 035 $a(SSID)ssj0000634238 035 $a(PQKBManifestationID)12239665 035 $a(PQKBTitleCode)TC0000634238 035 $a(PQKBWorkID)10640872 035 $a(PQKB)10518607 035 $a(MiAaPQ)EBC914704 035 $a(Au-PeEL)EBL914704 035 $a(CaPaEBR)ebr10566560 035 $a(CaONFJC)MIL359877 035 $a(EXLCZ)992670000000180880 100 $a20110228d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDifficult diagnosis in breast pathology$b[electronic resource] /$fedited by Juan P. Palazzo 205 $a1st ed. 210 $aNew York $cDemos Medical$d2011 215 $a1 online resource (259 p.) 300 $aDescription based upon print version of record. 311 $a1-933864-79-6 320 $aIncludes bibliographical references and index. 327 $aThe diagnostic challenges of core needle biopsy interpretation / Cangiarella -- Morphologic precursors of mammary carcinoma and their mimics / Edi Brogi, Adriana D. Corben, and Melissa P. Murray -- Papillary lesions of the breast / Cansu Karakas, Erika Resetkova, and Aysegul A. Sahin -- Flat epithelial atypia / Melinda F. Lerwill -- Adenosis : mimickers of carcinoma / Juan Palazzo and Jose Palacios Calvo -- Microinvasive carcinoma : diagnosis and pitfalls / Dilip Giri -- Carcinomas with good prognosis / Melissa E. Sanders -- Mesenchymal lesions of the breast / Melinda E. Sanders, John S.J. Brooks, and Juan P. Palazzo -- Lymphomas of the breast / Judith A. Ferry -- Immunohistochemistry in breast pathology / Felipe C. Geyer, Magali Lacroix-Triki, and Jorge S. Reis-Filho. 330 $aBreast cancer is the second leading cause of cancer death in women in the United States. For the pathologist, almost any breast lesion may produce diagnostic difficulty, especially due to frequently small samples (core biopsy specimens) and a variety of mimics and variants seen in specific types of lesions. Additionally, the difficulty of breast lesion diagnosis has risen dramatically in recent years due to the increased emphasis on stratifying patients for appropriate therapy on an individual basis; the wider range of both local and systemic therapeutic options, and the potential for earlier 606 $aBreast$xDiseases$xDiagnosis 606 $aTumor markers 615 0$aBreast$xDiseases$xDiagnosis. 615 0$aTumor markers. 676 $a618.1/9 701 $aPalazzo$b Juan P$01641200 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910812828503321 996 $aDifficult diagnosis in breast pathology$93985170 997 $aUNINA